维普期刊资源整合服务平台（V6.5）

28篇 您的检索式：作者名="Metman"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Effects of supra-threshold levodopa doses on dyskinesias in advanced Parkinson's disease显示文摘	Metman LV van den Munckhof P Klaaseen AA	1997	Neurology1997，49，：	1
2	Deep brain stimulation for Parkinson's disease:prevalence of adverse events and need for standardized reporting显示文摘	Videnovic A Metman LV	2008	Mov Disord2008，23，：	1
3	Continuous transdermal dopa-minergic stimulation in advanced Parkinson's disease 显示文摘	METMAN LV GILLESPIE M FARMER C	2001	Clin Neuropharmacol2001，24，3：	1
4	Topographic mapping of human motor cortex with transcranial magnetic stimulation: Homunculus revisited显示文摘	Leo Verhagen Metman Jacqueline S. Bellevich Seth M. Jones Matt D. Barber Leopold J. Streletz	1993	Brain Topography1993，，1：	1
5	Effects of bilateral posteroventral pallidotomy on gait of subjects with Parkinson disease显示文摘	Siegel KL Metman LV	2000	Arch Neurol2000，57，2：	1
6	Effects of bilateral posteroventral pallidotomy on gait of subjects with Parkinson disease显示文摘	Siegel KL Metman LV	2000	Arch Neurol2000，57，：	1
7	Treating festinating speech with al- tered auditory feedback in Parkinson's disease - the first re- port of a clinical trial显示文摘	Wang EQ Metman LV	2008	Movement Disorders2008，23，1：	1
8	Load capacity of multi-recess hydrostatic journal bearings at high eccentricities显示文摘	Metman K J Muijderman E A G J J van Heijningen	1986	Tribology International1986，19，1：	1
9	Crossover comparison of IPX066 and a standard levodopa formulation in advanced Parkinson's disease显示文摘	HAUSER R A ELLENBOGEN A L METMAN L V	2011	Mov Disord2011，26，12：	1
10	Transdermal dopaminergic D(2) receptor agonist therapy in Parkinson's disease with N-0923 TDS:a double-blind,placebo-controlled study显示文摘	Hutton JT Metman LV Chase TN	2001	Mov Disord2001，16，：	1
11	Continuous transdermal dopaminergic stimulation in advanced Parkinson's disease显示文摘	Metman LV Gillespie M Farmer C	2001	Clin Neuropharmacol2001，24，：	1
12	Severe topiramate-associated hyperthermia resulting in persistent neurological dysfunction 显示文摘	Galicia SC Lewis SL Metman LV	2005	Clin Neuropharmacol2005，28，2：	1
13	Transdermal dopaminergic D(2) receptor agonist therapy in Parkinson' s disease with N-0923 TDS: a double-blind, placebo-controlled study显示文摘	HUTTON J T METMAN L V	2001	Mov Disord2001，16，3：	1
14	Transdermal dopaminergic D2 receptor agonist therapy inParkinson's disease with N- 0923 TDS: a double- blind, placebo-controlled study显示文摘	Metman L V Chase T N	2001	Mov Disord2001，16，3：	1
15	Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson's disease 显示文摘	Metman LV Del DP Van DM	1998	Neurology1998，50，5：	1
16	Risk factors for immediate complications after progressive pneumatic dilation for achalasia显示文摘	Metman E H Lagasse J P Alterocho L	1999	Aim J Gastrentreol1999，94，5：	1
17	Crossover comparison of IPX066 and a standard levodopa formulation in advanced Parkinson's disease显示文摘	HAUSER R A ELLENBOGEN A L METMAN L V	2011	Mov Disord2011，26，12：	1
18	Risk factors for immediate complications after progressive pneumatic dilation for achalasia 显示文摘	Metman EH lagasse JP d'Alteroehe L	1999	Am J Gastroenterol1999，94，5：	1
19	Effects of subthalamic nucleus stimulation and medication on resting and postural tremor in Parkinson's disease显示文摘	Sturman MM Vaillancourt DE Metman LV	2004	Brain2004，127，：	1
20	Effects of bilateral posteroventral pallidoto- my on gait of subjects with Parkinson disease显示文摘	Siegel KL Metman LV	2000	Arch Neurot2000，57，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示